A Study of Automated Axicabtagene Ciloleucel for R/R Large B-cell Lymphoma.
Clinical trial NCT07606937 · RECRUITING
Trial details
- NCT number
- NCT07606937
- Sponsor
- Shenzhen Fosun Kairos Biotechnology Co., Ltd.
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-12
- Primary completion
- 2026-11-30
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.